Posted by Michael Wonder on 18 Dec 2021
PHARMAC bundle deal life-giving for some cancer patients, but medics say NZ still 'playing catch up' for best treatments
16 December 2021 - About 100 patients with stage 3 lung cancer stand to gain extra years of life from a PHARMAC “bundle” deal under consideration with pharmaceutical company Astra Zeneca.
Under the deal, PHARMAC would subsidise the immunotherapy drug durvalumab (Imfinzi) for people with stage 3 non-small cell lung cancer.
